AI-Powered symptom watch aims to keep head and neck cancer patients out of the ER
NCT ID NCT05338905
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using machine learning to closely monitor symptoms can help head and neck cancer patients avoid urgent hospital visits during radiation therapy. Researchers will compare intensive symptom tracking plus standard care to standard care alone in 72 patients with non-metastatic head and neck cancer. The goal is to see if early detection of worsening symptoms leads to better quality of life and fewer emergency visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intensive symptom surveillance with machine learning risk stratification
What this could lead to
If successful, this approach could help doctors catch worsening symptoms earlier and reduce the need for emergency hospital visits during radiation therapy.
What could go wrong
This is a small, early-stage study (72 participants) focused on non-metastatic disease, so results may not apply to all head and neck cancer patients. The intervention is observational and does not test a new drug or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States